330 related articles for article (PubMed ID: 32986883)
21. The Rising Costs of Alcohol-Associated Liver Disease in the United States.
Julien J; Ayer T; Tapper EB; Chhatwal J
Am J Gastroenterol; 2024 Feb; 119(2):270-277. PubMed ID: 37463414
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of alcoholic liver disease.
Torruellas C; French SW; Medici V
World J Gastroenterol; 2014 Sep; 20(33):11684-99. PubMed ID: 25206273
[TBL] [Abstract][Full Text] [Related]
23. Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder.
Arab JP; Addolorato G; Mathurin P; Thursz MR
Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2124-2134. PubMed ID: 36858144
[TBL] [Abstract][Full Text] [Related]
24. From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women.
Danpanichkul P; Ng CH; Muthiah M; Suparan K; Tan DJH; Duangsonk K; Sukphutanan B; Kongarin S; Harinwan N; Panpradist N; Takahashi H; Kawaguchi T; Vichitkunakorn P; Chaiyakunapruk N; Nathisuwan S; Huang D; Arab JP; Noureddin M; Mellinger JL; Wijarnpreecha K
Am J Gastroenterol; 2024 May; 119(5):893-909. PubMed ID: 38147513
[TBL] [Abstract][Full Text] [Related]
25. Covid-19 and alcohol associated liver disease.
Deutsch-Link S; Curtis B; Singal AK
Dig Liver Dis; 2022 Nov; 54(11):1459-1468. PubMed ID: 35933291
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive tests for alcohol-associated liver disease.
Israelsen M; Rungratanawanich W; Thiele M; Liangpunsakul S
Hepatology; 2024 Apr; ():. PubMed ID: 38607723
[TBL] [Abstract][Full Text] [Related]
27. Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease.
Vannier AGL; Przybyszewski EM; Shay J; Patel SJ; Schaefer E; Goodman RP; Luther J
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1571-1580.e7. PubMed ID: 35964893
[TBL] [Abstract][Full Text] [Related]
28. Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes.
Díaz LA; Fuentes-López E; Idalsoaga F; Ayares G; Corsi O; Arnold J; Cannistra M; Vio D; Márquez-Lomas A; Ramirez-Cadiz C; Medel MP; Hernandez-Tejero M; Ferreccio C; Lazo M; Roblero JP; Cotter TG; Kulkarni AV; Kim W; Brahmania M; Louvet A; Tapper EB; Dunn W; Simonetto D; Shah VH; Kamath PS; Lazarus JV; Singal AK; Bataller R; Arrese M; Arab JP
J Hepatol; 2024 Mar; 80(3):409-418. PubMed ID: 37992972
[TBL] [Abstract][Full Text] [Related]
29. Trends in the management and burden of alcoholic liver disease.
Mathurin P; Bataller R
J Hepatol; 2015 Apr; 62(1 Suppl):S38-46. PubMed ID: 25920088
[TBL] [Abstract][Full Text] [Related]
30. Drinking and laboratory biomarkers, and nutritional status characterize the clinical presentation of early-stage alcohol-associated liver disease.
Vatsalya V; Royer AJ; Jha SK; Parthasarathy R; Tiwari H; Feng W; Ramchandani VA; Kirpich IA; McClain CJ
Adv Clin Chem; 2023; 114():83-108. PubMed ID: 37268335
[TBL] [Abstract][Full Text] [Related]
31. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).
Arab JP; Roblero JP; Altamirano J; Bessone F; Chaves Araujo R; Higuera-De la Tijera F; Restrepo JC; Torre A; Urzua A; Simonetto DA; Abraldes JG; Méndez-Sánchez N; Contreras F; Lucey MR; Shah VH; Cortez-Pinto H; Bataller R
Ann Hepatol; 2019; 18(3):518-535. PubMed ID: 31053546
[TBL] [Abstract][Full Text] [Related]
32. Management of alcohol misuse in patients with liver diseases.
Peng JL; Patel MP; McGee B; Liang T; Chandler K; Tayarachakul S; O'Connor S; Liangpunsakul S
J Investig Med; 2017 Mar; 65(3):673-680. PubMed ID: 27940551
[TBL] [Abstract][Full Text] [Related]
33. Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study.
Wu M; Qin S; Tan C; Li S; Xie O; Wan X
BMC Med; 2023 Jul; 21(1):277. PubMed ID: 37501074
[TBL] [Abstract][Full Text] [Related]
34. Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.
Singal AK; Kwo P; Kwong A; Liangpunsakul S; Louvet A; Mandrekar P; McClain C; Mellinger J; Szabo G; Terrault N; Thursz M; Winder GS; Kim WR; Shah VH
Hepatology; 2022 Apr; 75(4):1026-1037. PubMed ID: 34496071
[TBL] [Abstract][Full Text] [Related]
35. Therapy for alcoholic liver disease.
Jaurigue MM; Cappell MS
World J Gastroenterol; 2014 Mar; 20(9):2143-58. PubMed ID: 24605013
[TBL] [Abstract][Full Text] [Related]
36. Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy.
Tarli C; Mirijello A; Addolorato G
Semin Liver Dis; 2022 May; 42(2):138-150. PubMed ID: 35292951
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of alcoholic liver disease and its association with socioeconomic status in north-eastern China.
Wang H; Ma L; Yin Q; Zhang X; Zhang C
Alcohol Clin Exp Res; 2014 Apr; 38(4):1035-41. PubMed ID: 24428769
[TBL] [Abstract][Full Text] [Related]
38. Improving alcohol treatment engagement using integrated behavioral interventions in alcohol-associated liver disease: A randomized pilot trial.
Mellinger JL; Medley S; Kidwell KM; Asefah H; Winder GS; Fernandez AC; Lok ASF; Blow F
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37708435
[TBL] [Abstract][Full Text] [Related]
39. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
Horie Y; Yamagishi Y; Ishii H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
[TBL] [Abstract][Full Text] [Related]
40. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.
Lackner C; Spindelboeck W; Haybaeck J; Douschan P; Rainer F; Terracciano L; Haas J; Berghold A; Bataller R; Stauber RE
J Hepatol; 2017 Mar; 66(3):610-618. PubMed ID: 27894795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
